Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 1/20 | 0.51 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.46 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.46 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.46 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.46 |
| ▸ | CSF1R | P07333 | 1/20 | 0.46 |
| ▸ | FER | P16591 | 1/20 | 0.46 |
| ▸ | CDK2 | P24941 | 1/20 | 0.46 |
| ▸ | MARK3 | P27448 | 1/20 | 0.46 |
| ▸ | FLT4 | P35916 | 1/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.46 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.46 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.46 |
| ▸ | CLK2 | P49760 | 1/20 | 0.46 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.46 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.46 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.46 |
| ▸ | STK3 | Q13188 | 1/20 | 0.46 |
| ▸ | CAMK2B | Q13554 | 1/20 | 0.46 |
| ▸ | CAMK2G | Q13555 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6500807 | 0.90 | DCLK1 (0.48) | AURKADCLK1PRKD3MAP4K4CHEK2 | |
| SCHEMBL6318486 | 0.90 | DCLK1 (0.52) | DCLK1PRKD3MAP4K4CHEK2CSF1R | |
| SCHEMBL5375043 | 0.79 | CDK2 (0.46) | DCLK1PRKD3MAP4K4CHEK2CSF1R | |
| SCHEMBL5372291 | 0.76 | MAP2K4 (0.42) | AURKACSNK1DAURKBMKNK1FGFR1 | |
| SCHEMBL31423230 | 0.76 | DCLK1 (0.65) | AURKADCLK1PRKD3MAP4K4CHEK2 | |
| SCHEMBL4008208 | 0.76 | DCLK1 (0.65) | AURKADCLK1PRKD3MAP4K4CHEK2 | |
| SCHEMBL5373376 | 0.74 | NTRK1 (0.44) | CLK2DYRK1AMKNK1LRRK2TTK | |
| SCHEMBL5372619 | 0.73 | MAPT (0.52) | AURKAAURKBHPGDMAPTMKNK1 | |
| SCHEMBL5382060 | 0.72 | NTRK1 (0.45) | CSNK1DMKNK1LRRK2JAK2MAP2K4 | |
| SCHEMBL5374860 | 0.71 | NTRK1 (0.42) | DCLK1PRKD3MAP4K4CHEK2CSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6919386-B2 | Polyether based preparations and the use thereof | 3M ESPE AG (DE) | 2005-07-19 | — | — | US | disclosed |
| US-20030109596-A1 | Polyether based preparations and the use thereof | 3M DEUTSCHLAND GMBH (DE) | 2003-06-12 | — | — | US | disclosed |
| US-20020103229-A1 | Indazole derivatives as JNK inhibitors and compositions and methods related thereto | SIGNAL PHARMACEUTICALS, LLC | 2002-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020103229-A1 | Indazole derivatives as JNK inhibitors and compositions and methods related thereto | MAP3K7, MAP3K1, MAP3K8 | AURKA 1001/4885DCLK1 1054/4885PRKD3 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.